Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chairman and CEO

President and CEO

Rain Oncology Inc., a late-stage precision oncology company, engages in developing therapies that target oncogenic drivers to genetically select patients in the United States. The company's lead product candidate is milademetan, a small molecule oral inhibitor of MDM2-p53 complex that reactivates p53. The company was formerly known as Rain Therapeutics Inc. and changed its name to Rain Oncology Inc. in December 2022. Rain Oncology Inc. was incorporated in 2017 and is headquartered in Newark, California.

Rain Oncology Inc., a late-stage precision oncology company, engages in developing therapies that target oncogenic drivers to genetically ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-26	Premium	sold	Premium	Premium	Premium	-
2024-01-26	Premium	sold	Premium	Premium	Premium	-
2024-01-26	Premium	sold	Premium	Premium	Premium	See Remarks
2024-01-26	Premium	sold	Premium	Premium	Premium	-
2024-01-26	Premium	sold	Premium	Premium	Premium	Chairman and CEO
2024-01-26	Premium	sold	Premium	Premium	Premium	-
2024-01-25	Premium	sold	Premium	Premium	Premium	-
2024-01-25	Premium	sold	Premium	Premium	Premium	-
2023-12-18	Premium	sold	Premium	Premium	Premium	-
2023-12-15	Premium	sold	Premium	Premium	Premium	-
2023-12-14	Premium	sold	Premium	Premium	Premium	-
2023-10-13	Premium	bought	Premium	Premium	Premium	-
2023-10-12	Premium	bought	Premium	Premium	Premium	-
2023-10-11	Premium	bought	Premium	Premium	Premium	-
2023-06-01	Premium	bought	Premium	Premium	Premium	-
2023-05-31	Premium	bought	Premium	Premium	Premium	-
2023-05-30	Premium	bought	Premium	Premium	Premium	-
2023-05-22	Premium	sold	Premium	Premium	Premium	-
2022-11-22	Premium	bought	Premium	Premium	Premium	-
2022-11-21	Premium	bought	Premium	Premium	Premium	-
2022-11-08	Premium	bought	Premium	Premium	Premium	-
2022-11-08	Premium	bought	Premium	Premium	Premium	-
2022-11-04	Premium	bought	Premium	Premium	Premium	-
2022-07-06	Premium	acquired	Premium	Premium	Premium	See Remarks
2022-06-01	Premium	bought	Premium	Premium	Premium	Chairman and CEO

RAIN - Rain Therapeutics Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for RAIN